2. Introduction
The urinary tract is a common site of infection in the
pediatric population.Unlike the generally benign course of
urinary tract infection (UTI) in the adult population.
UTI in the pediatric population is well recognized as a
cause of acute morbidity and chronic medical conditions,
such as hypertension and renal insufficiency in adulthood.
3.
As a result, it is crucial to have a clear understanding of the
pathogenesis of UTI, risk factors, indications for diagnostic
tests, and the appropriate uses of antimicrobial agents in
the management of children with UTI.
4.
The urinary tract (ie, kidney, ureter, bladder, and urethra) is a
closed, normally sterile space lined with mucosa composed of
epithelium known as transitional cells.
The main defense mechanism against UTI is constant
antegrade flow of urine from the kidneys to the bladder with
intermittent complete emptying of the bladder via the
urethra.
5.
This washout effect of the urinary flow usually clears the
urinary tract of pathogens
The urine itself also has specific antimicrobial characteristics,
including low urine pH, polymorphonuclear cells, and Tamm
Horsfall glycoprotein, which inhibits bacterial adherence to
the bladder mucosal wawall
6.
UTI occurs when the introduction of pathogens into this space
is associated with adherence to the mucosa of the urinary
tract.
If uropathogens are cleared inadequately by the washout
effect of voiding, then microbial colonization potentially
develops.
7.
Colonization may be followed by microbial multiplication and
an associated inflammatory response.
Bacteria that cause UTI in otherwise healthy hosts often
exhibit distinctive properties—known as virulence factors
8.
Urinary tract infections (UTIs) occur in 1% of boys and 1-3% of
girls.
T he prevalence of UTIs varies with age.
During the 1st yr of life, the male : female ratio is 2.8-5.4 :
1.
Beyond 1-2 yr, there is a female preponderance, with a
male : female ratio of 1 : 10.
9. • Bacterial infections are the most common.
• E coli is the most common causing 75-90% of UTI episo
des. Other bacteria include:
• Klebsiella species
• Proteus species
• Enterococcus species
• Staphylococcus saprophyticus
• Adenovirus (rare)
• Fungal in immune compromised patients
Etiology
11. CLINICAL MANIFESTATIONS AND CLASSIFICATION
The 3 basic forms of UTI are:-
.1
Pypyelonephritis
.2
Cystitis, and
.3
Asymptomatic bacteriuria.
12. Clinical Pyelonephritis
Clinical pyelonephritis is characterized by any or all of the
following:
–
abdominal, back, or flank pain;
–
fever; malaise; nausea; vomiting; and,
–
occasionally, diarrhea.
–
Fever may be the only manifestation.
13.
Newborns can show nonspecific symptoms such as poor
feeding, irritability, jaundice, and weight loss.
Pyelonephritis is the most common serious bacterial infection
in infants younger than 24 mo of age who have fever without
an obvious focus
14.
These symptoms are an indication that there is bacterial
involvement of the upper urinary tract.
Acute pyelonephritis can result in renal injury, termed
pyelonephritic scarring.
15. Cystitis
Cystitis indicates that there is bladder involvement
symptoms include:-
dysuria, urgency, frequency,
suprapubic pain,
incontinence, and malodorous urine
16.
Cystitis does not cause fever and does not result in renal
injury.
Malodorous urine is not specific for a UTI.
17. Asymptomatic Bacteriuria
Asymptomatic bacteriuria refers to a condition in which there
is a positive urine culture without any manifestations of
infection.
•
It is most common in girls
•
The incidence is <1% in preschool and schoolage girls and is
rare in boboy
•
This condition is benign and does not cause renal injury,
except in pregnant women, in whom asymptomatic
bacteriuria, if left untreated, can result in a symptomatic UTI.
18. Diagnosis
•
The definitive diagnosis of a UTI requires the isolation of at
least one uropathogen from a urine culture
•
Urine, which should be obtained before the initiation of
antimicrobial therapy, can be collected by various methods.
19. •
The AAP recommends suprapubic aspiration or urethral
catheterization to establish a diagnosis of UTI in neonates and
young children.
•
Aclean-catch specimen may be obtained from older children
and young adults.
20. Urinalysis:
– A urine specimen that is found to be positive for nitrite, le
ukocyte esterase, or blood may indicate a UTI.
– Microscopic examination can evaluate presence of WBCs (
>5 per high-power field), RBCs, bacteria, casts, and skin co
ntamination (e.g., epithelial cells).
21.
22. TREATMENT
Acute cystitis
–
3- to 5-day course of therapy with
trimethoprim-sulfamethoxazole (TMP-SMX) trimethoprim
is effective against many strains of E. coli.
23.
Nitrofurantoin (5-7 mg/ kg/24 hr in 3-4 divided doses) also is
effective and has the advantage of being active against
Klebsiella and Enterobacter organisms.
Amoxicillin (50 mg/kg/24 hr) also is effective as initial
treatment but has a high rate of bacterial resistance.
24.
Pyelonephritis
In acute febrile infections suggesting a 7-14 day course of
broad-spectrum antibiotics capable of reaching significant
tissue levels is preferable.
25. Indication for admission
Children who are :-
dehydrated, vomiting, unable to drink fluids,
1 mo of age or younger,
have complicated infection,
in whom urosepsis is a possibility
admitted to the hospital for IV rehydration and IV
antibiotic therapy.
26. Reurrent UTI:
Two or more UTIs over a six months period.
There will be a period of remission followed by a recurrence
of the infection
Causes:
Inadequate treatment either due to compliance or improper
prescription.
unrecognized site of bacterial persistence such as small infected calculus
o
un recognized anatomic abnormality.